$5.58
0.050.94%
Pre-Market: 4:54 PM EDT
Comments
Loading...
Cara Therapeutics Insider Trading Activity | NASDAQ:CARA | Benzinga
Track the latest Cara Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Cara Therapeutics stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Cara Therapeutics Inc Insiders Doing?
At Cara Therapeutics Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 746.00 shares worth $3.55K, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On March 4, 2025, Scott Terrillion, the company's SEC'Y; CHIEF COMPLIANCE & G.C. sold 163 shares for $4.76 each.
- On February 6, 2025, Christopher Posner, the company's PRESIDENT AND CEO sold 372 shares for $4.72 each.
- On March 4, 2025, Christopher Posner, the company's PRESIDENT AND CEO sold 583 shares for $4.75 each.
Ownership Statistics for Cara Therapeutics Inc
Shares Outstanding
4.574M
Insider Shares Owned
2.960M
Insider Percentage Owned
64.8%
Institutional Shares Held
2.841M
Institutional Percentage Held
8.27%
| Mar 04, 2025 | Christopher Posner | PRESIDENT AND CEO | -583.00 | $4.75 | -$2.77K | SELL | -4.26% | 13.11K | Feb 28 | View |
| Mar 04, 2025 | Scott Terrillion | SEC'Y; CHIEF COMPLIANCE & G.C. | -163.00 | $4.76 | -$775.88 | SELL | -2.22% | 7.19K | Feb 28 | View |
| Feb 06, 2025 | Christopher Posner | PRESIDENT AND CEO | -372.00 | $4.72 | -$1.76K | SELL | -2.65% | 13.69K | Feb 04 | View |
| Nov 06, 2024 | Christopher Posner | PRESIDENT AND CEO | -3.67K | $0.29 | -$1.06K | SELL | -2.13% | 168.77K | Nov 04 | View |
| Aug 02, 2024 | Christopher Posner | PRESIDENT AND CEO | -4.15K | $0.35 | -$1.45K | SELL | -2.35% | 172.44K | Aug 01 | View |
| May 06, 2024 | Christopher Posner | PRESIDENT AND CEO | -3.94K | $0.75 | -$2.95K | SELL | -2.18% | 176.59K | May 02 | View |
| Apr 09, 2024 | Joana Goncalves | CHIEF MEDICAL OFFICER | -2.75K | $0.83 | -$2.28K | SELL | -4.91% | 53.37K | Apr 05 | View |
| Apr 09, 2024 | Scott Terrillion | SEC'Y; CHIEF COMPLIANCE & G.C. | -2.75K | $0.83 | -$2.28K | SELL | -3.03% | 88.25K | Apr 05 | View |
| Mar 04, 2024 | Scott Terrillion | SEC'Y; CHIEF COMPLIANCE & G.C. | -3.29K | $0.89 | -$2.93K | SELL | -3.49% | 91.00K | Feb 29 | View |
| Mar 04, 2024 | Christopher Posner | PRESIDENT AND CEO | -5.83K | $0.89 | -$5.19K | SELL | -3.13% | 180.52K | Feb 29 | View |
| Mar 04, 2024 | Joana Goncalves | CHIEF MEDICAL OFFICER | -3.29K | $0.89 | -$2.93K | SELL | -5.54% | 56.12K | Feb 29 | View |
| Feb 12, 2024 | Scott Terrillion | SEC'Y; CHIEF COMPLIANCE & G.C. | -7.77K | $0.53 | -$4.12K | SELL | -7.61% | 94.29K | Feb 08 | View |
| Feb 12, 2024 | Ryan Maynard | CHIEF FINANCIAL OFFICER | -5.49K | $0.53 | -$2.91K | SELL | -40.65% | 8.01K | Feb 08 | View |
| Feb 12, 2024 | Joana Goncalves | CHIEF MEDICAL OFFICER | -7.77K | $0.53 | -$4.12K | SELL | -11.57% | 59.41K | Feb 08 | View |
| Feb 12, 2024 | Christopher Posner | PRESIDENT AND CEO | -35.58K | $0.53 | -$18.85K | SELL | -16.03% | 186.35K | Feb 08 | View |
| Feb 05, 2024 | Christopher Posner | PRESIDENT AND CEO | 57.52K | $0.55 | -$2.74K | GRANT | 34.98% | 221.93K | Feb 01 | View |
| Nov 03, 2023 | Christopher Posner | PRESIDENT AND CEO | -3.80K | $1.22 | -$4.63K | SELL | -2.26% | 164.41K | Nov 02 | View |
| Aug 04, 2023 | Christopher Posner | PRESIDENT AND CEO | -4.31K | $3.07 | -$13.22K | SELL | -2.50% | 168.21K | Aug 03 | View |
| Jun 27, 2023 | Scott Terrillion | SEC'Y; CHIEF COMPLIANCE & G.C. | -2.48K | $3.51 | -$8.72K | SELL | -2.73% | 88.56K | Jun 23 | View |
| Jun 27, 2023 | PhD Frederique Menzaghi | CHIEF SCIENTIFIC OFF,SVP-R&D | -2.99K | $3.51 | -$10.51K | SELL | -1.91% | 153.75K | Jun 23 | View |
| Jun 27, 2023 | Joana Goncalves | CHIEF MEDICAL OFFICER | -2.72K | $3.51 | -$9.56K | SELL | -4.83% | 53.68K | Jun 23 | View |
| May 09, 2023 | Christopher Posner | PRESIDENT AND CEO | -3.87K | $4.40 | -$17.02K | SELL | -2.19% | 172.51K | May 05 | View |
| Apr 06, 2023 | Scott Terrillion | SEC'Y; CHIEF COMPLIANCE & G.C. | -2.48K | $4.91 | -$12.18K | SELL | -2.65% | 91.05K | Apr 04 | View |
| Apr 06, 2023 | Joana Goncalves | CHIEF MEDICAL OFFICER | -2.48K | $4.91 | -$12.18K | SELL | -4.21% | 56.40K | Apr 04 | View |
| Apr 06, 2023 | PhD Frederique Menzaghi | CHIEF SCIENTIFIC OFF,SVP-R&D | -2.73K | $4.91 | -$13.42K | SELL | -1.71% | 156.74K | Apr 04 | View |
| Mar 07, 2023 | Christopher Posner | PRESIDENT AND CEO | -5.99K | $9.71 | -$58.13K | SELL | -3.28% | 176.38K | Mar 03 | View |
| Mar 07, 2023 | PhD Frederique Menzaghi | CHIEF SCIENTIFIC OFF,SVP-R&D | -6.80K | $9.71 | -$66.05K | SELL | -4.09% | 159.47K | Mar 03 | View |
| Mar 07, 2023 | Scott Terrillion | SEC'Y; CHIEF COMPLIANCE & G.C. | -6.26K | $9.71 | -$60.75K | SELL | -6.27% | 93.53K | Mar 03 | View |
| Mar 07, 2023 | Joana Goncalves | CHIEF MEDICAL OFFICER | -6.22K | $9.71 | -$60.41K | SELL | -9.56% | 58.88K | Mar 03 | View |
| Feb 17, 2023 | Joana Goncalves | CHIEF MEDICAL OFFICER | -2.27K | $10.20 | -$23.10K | SELL | -3.36% | 65.11K | Feb 16 | View |
| Feb 03, 2023 | Christopher Posner | PRESIDENT AND CEO | -4.19K | $11.80 | -$49.45K | SELL | -2.25% | 182.37K | Feb 02 | View |
| Jan 19, 2023 | Joana Goncalves | CHIEF MEDICAL OFFICER | -2.27K | $10.81 | -$24.48K | SELL | -3.25% | 67.37K | Jan 17 | View |
| Jan 03, 2023 | Joana Goncalves | CHIEF MEDICAL OFFICER | -2.27K | $10.18 | -$23.06K | SELL | -3.15% | 69.64K | Dec 29 | View |
| Dec 23, 2022 | PhD Frederique Menzaghi | CHIEF SCIENTIFIC OFF,SVP-R&D | -3.51K | $11.27 | -$39.51K | SELL | -2.07% | 166.28K | Dec 21 | View |
| Dec 23, 2022 | Joana Goncalves | CHIEF MEDICAL OFFICER | -2.99K | $11.27 | -$33.72K | SELL | -4.00% | 71.90K | Dec 21 | View |
| Dec 23, 2022 | Scott Terrillion | SEC'Y; CHIEF COMPLIANCE & G.C. | -2.56K | $11.27 | -$28.86K | SELL | -2.50% | 99.78K | Dec 21 | View |
| Nov 18, 2022 | Christopher Posner | PRESIDENT AND CEO | -14.47K | $11.13 | -$161.05K | SELL | -7.20% | 186.56K | Nov 16 | View |
| Sep 16, 2022 | MARTIN VOGELBAUM | DIRECTOR | -10.80K | $10.28 | -$111.02K | SELL | -19.36% | 44.99K | Sep 14 | View |
| Jul 19, 2022 | Jeffrey Ives | DIRECTOR | -3.60K | $9.05 | -$32.58K | SELL | -18.87% | 15.48K | Jul 15 | View |
| Jul 19, 2022 | HARRISON BAINS JR | DIRECTOR | -7.20K | $9.05 | -$65.16K | SELL | -22.31% | 25.08K | Jul 15 | View |
| Apr 05, 2022 | Scott Terrillion | SEC'Y; CHIEF COMPLIANCE & G.C. | -1.64K | $11.91 | -$19.56K | SELL | -1.58% | 102.34K | Apr 01 | View |
| Apr 05, 2022 | Joana Goncalves | CHIEF MEDICAL OFFICER | -1.64K | $11.91 | -$19.56K | SELL | -2.15% | 74.89K | Apr 01 | View |
| Apr 05, 2022 | PhD Frederique Menzaghi | CHIEF SCIENTIFIC OFF,SVP-R&D | -1.78K | $11.91 | -$21.25K | SELL | -1.04% | 169.78K | Apr 01 | View |
| Apr 05, 2022 | Christopher Posner | PRESIDENT AND CEO | -2.01K | $12.67 | -$25.42K | SELL | -0.99% | 201.03K | Apr 04 | View |
| Mar 04, 2022 | Charles Thomas Reilly | CHIEF FINANCIAL OFFICER | -2.04K | $11.38 | -$23.26K | SELL | -5.13% | 37.81K | Mar 03 | View |
| Mar 04, 2022 | Scott Terrillion | SEC'Y; CHIEF COMPLIANCE & G.C. | -1.79K | $11.38 | -$20.34K | SELL | -1.69% | 103.99K | Mar 03 | View |
| Mar 01, 2022 | Scott Terrillion | SEC'Y; CHIEF COMPLIANCE & G.C. | 23.36K | $10.29 | -$20.29K | GRANT | 28.35% | 105.77K | Feb 25 - Feb 28 | View |
| Mar 01, 2022 | PhD Frederique Menzaghi | CHIEF SCIENTIFIC OFF,SVP-R&D | 17.89K | $10.29 | -$21.75K | GRANT | 11.64% | 171.56K | Feb 25 | View |
| Mar 01, 2022 | Joana Goncalves | CHIEF MEDICAL OFFICER | 18.03K | $10.29 | -$20.29K | GRANT | 30.81% | 76.53K | Feb 25 | View |
| Nov 16, 2021 | Jeffrey Ives | DIRECTOR | -8.18K | $16.04 | -$131.21K | SELL | -53.19% | 7.20K | Nov 12 | View |
| Nov 03, 2021 | Joana Goncalves | CHIEF MEDICAL OFFICER | -1.00K | $17.15 | -$17.15K | SELL | -2.13% | 45.90K | Nov 01 | View |
| Oct 28, 2021 | Joana Goncalves | CHIEF MEDICAL OFFICER | -1.00K | $15.00 | -$15.00K | SELL | -2.09% | 46.90K | Oct 27 | View |
| Sep 09, 2021 | DEREK CHALMERS | PRESIDENT & CEO | -20.00K | $15.47 | -$309.40K | SELL | -1.98% | 991.40K | Sep 07 | View |
| Sep 01, 2021 | Scott Terrillion | SEC'Y; CHIEF COMPLIANCE & G.C. | -1.76K | $14.20 | -$24.98K | SELL | -2.42% | 70.92K | Aug 30 | View |
| Sep 01, 2021 | Charles Thomas Reilly | CHIEF FINANCIAL OFFICER | -1.98K | $14.20 | -$28.14K | SELL | -37.16% | 3.35K | Aug 30 | View |
| Sep 01, 2021 | PhD Frederique Menzaghi | CHIEF SCIENTIFIC OFF,SVP-R&D | -3.85K | $14.20 | -$54.63K | SELL | -2.65% | 141.07K | Aug 30 | View |
| Sep 01, 2021 | Joana Goncalves | CHIEF MEDICAL OFFICER | -2.11K | $14.20 | -$29.96K | SELL | -4.22% | 47.90K | Aug 30 | View |
| Sep 01, 2021 | DEREK CHALMERS | PRESIDENT & CEO | -8.44K | $14.20 | -$119.85K | SELL | -0.83% | 1.01M | Aug 30 | View |
| Jun 07, 2021 | MARTIN VOGELBAUM | DIRECTOR | 5.76K | $13.05 | -$112.75K | GRANT | 40.00% | 20.16K | Jun 03 - Jun 07 | View |
| Jun 07, 2021 | Christopher Posner | DIRECTOR | 4.90K | $13.04 | -$30.04K | GRANT | 43.71% | 16.10K | Jun 03 - Jun 07 | View |
| Jun 07, 2021 | Jeffrey Ives | DIRECTOR | 4.68K | $13.05 | -$32.89K | GRANT | 43.74% | 15.38K | Jun 03 - Jun 07 | View |
| Apr 23, 2021 | Joana Goncalves | CHIEF MEDICAL OFFICER | -3.00K | $27.63 | -$82.89K | SELL | -6.44% | 43.61K | Apr 21 | View |
| Mar 24, 2021 | Joana Goncalves | CHIEF MEDICAL OFFICER | -3.00K | $19.65 | -$58.95K | SELL | -8.93% | 30.61K | Mar 22 | View |
| Mar 08, 2021 | PhD Frederique Menzaghi | CHIEF SCIENTIFIC OFF,SVP-R&D | 6.64K | $17.98 | -$60.38K | GRANT | 5.89% | 119.32K | Mar 04 - Mar 05 | View |
| Mar 08, 2021 | Scott Terrillion | SEC'Y; CHIEF COMPLIANCE & G.C. | 6.91K | $17.98 | -$55.56K | GRANT | 15.55% | 51.34K | Mar 04 - Mar 05 | View |
| Mar 08, 2021 | Joana Goncalves | CHIEF MEDICAL OFFICER | 6.91K | $17.98 | -$55.61K | GRANT | 25.87% | 33.61K | Mar 04 - Mar 05 | View |
| Mar 08, 2021 | DEREK CHALMERS | PRESIDENT & CEO | 6.90K | $17.98 | -$55.79K | GRANT | 0.73% | 950.51K | Mar 04 - Mar 05 | View |
| Feb 25, 2021 | Scott Terrillion | SEC'Y; CHIEF COMPLIANCE & G.C. | 2.00K | $19.33 | -$77.40K | GRANT | 4.70% | 44.43K | Feb 23 - Feb 25 | View |
| Feb 25, 2021 | PhD Frederique Menzaghi | CHIEF SCIENTIFIC OFF,SVP-R&D | 3.00K | $19.33 | -$96.71K | GRANT | 2.73% | 112.68K | Feb 23 - Feb 25 | View |
| Feb 25, 2021 | Joana Goncalves | CHIEF MEDICAL OFFICER | 628.00 | $19.33 | -$65.18K | GRANT | 2.41% | 26.70K | Feb 23 - Feb 25 | View |
| Feb 25, 2021 | DEREK CHALMERS | PRESIDENT & CEO | 7.02K | $19.33 | -$226.72K | GRANT | 0.75% | 943.61K | Feb 23 - Feb 25 | View |
| Feb 24, 2021 | Joana Goncalves | CHIEF MEDICAL OFFICER | -2.00K | $19.73 | -$39.46K | SELL | -7.12% | 26.07K | Feb 22 | View |
| Jan 25, 2021 | Joana Goncalves | CHIEF MEDICAL OFFICER | -2.00K | $20.12 | -$40.24K | SELL | -6.65% | 28.07K | Jan 21 | View |
| Dec 30, 2020 | Scott Terrillion | — | -1.95K | $15.30 | -$29.77K | SELL | -4.38% | 42.44K | Dec 30 | View |
| Dec 30, 2020 | PhD Frederique Menzaghi | — | -2.81K | $15.30 | -$43.02K | SELL | -2.50% | 109.68K | Dec 30 | View |
| Dec 30, 2020 | Joana Goncalves | — | -1.30K | $15.30 | -$19.86K | SELL | -4.14% | 30.07K | Dec 30 | View |
| Dec 30, 2020 | DEREK CHALMERS | — | -6.08K | $15.30 | -$92.99K | SELL | -0.64% | 936.59K | Dec 30 | View |
| Dec 29, 2020 | DEREK CHALMERS | — | 13.75K | $16.00 | -$80.00K | GRANT OR AWARD | 1.48% | 942.67K | Dec 23 - Dec 28 | View |
| Dec 23, 2020 | Joana Goncalves | — | -2.00K | $15.00 | -$30.00K | SELL | -6.81% | 27.37K | Dec 21 | View |
| Dec 18, 2020 | DEREK CHALMERS | — | -5.00K | $14.95 | -$74.75K | SELL | -0.54% | 928.92K | Dec 16 | View |
| Dec 11, 2020 | DEREK CHALMERS | — | -7.50K | $15.29 | -$114.67K | SELL | -0.80% | 933.92K | Dec 10 | View |
| Nov 25, 2020 | Joana Goncalves | — | -2.00K | $15.31 | -$30.62K | SELL | -6.37% | 29.37K | Nov 23 | View |
| Nov 23, 2020 | Christopher Posner | — | -2.00K | $15.82 | -$31.64K | SELL | -15.15% | 11.20K | Nov 19 | View |
| Nov 19, 2020 | MARTIN VOGELBAUM | — | -6.00K | $16.09 | -$96.54K | SELL | -29.41% | 14.40K | Nov 17 | View |
| Nov 19, 2020 | DEREK CHALMERS | — | -11.80K | $16.00 | -$188.78K | SELL | -1.24% | 941.42K | Nov 17 | View |
| Nov 13, 2020 | Joana Goncalves | — | -2.00K | $15.00 | -$30.00K | SELL | -5.99% | 31.37K | Nov 10 | View |
| Oct 22, 2020 | Joana Goncalves | — | -2.00K | $15.00 | -$30.00K | SELL | -5.65% | 33.37K | Oct 20 | View |
| Sep 08, 2020 | DEREK CHALMERS | — | -3.20K | $16.00 | -$51.22K | SELL | -0.33% | 953.22K | Sep 03 | View |
| Aug 05, 2020 | DEREK CHALMERS | — | -5.00K | $16.42 | -$82.10K | SELL | -0.52% | 956.42K | Aug 03 | View |
| Jul 02, 2020 | DEREK CHALMERS | — | -5.00K | $17.11 | -$85.55K | SELL | -0.52% | 961.42K | Jul 01 | View |
| Jun 12, 2020 | Joana Goncalves | — | 19.37K | $15.20 | -$161.53K | GRANT OR AWARD | 121.08% | 35.37K | Jun 10 - Jun 12 | View |
| Jun 03, 2020 | DEREK CHALMERS | — | -5.00K | $16.01 | -$80.04K | SELL | -0.51% | 966.42K | Jun 01 - Jun 03 | View |
| Jun 03, 2020 | Jeffrey Ives | — | 0.00 | $12.97 | -$6.06K | OPTION EXERCISE | 0.00% | 6.00K | Jun 01 | View |
| May 22, 2020 | DEREK CHALMERS | — | -5.07K | $16.00 | -$81.14K | SELL | -0.52% | 971.42K | May 20 - May 22 | View |
| May 14, 2020 | DEREK CHALMERS | — | -4.93K | $16.00 | -$78.86K | SELL | -0.50% | 976.49K | May 12 | View |
| May 14, 2020 | Jeffrey Ives | — | 0.00 | $12.97 | -$15.15K | OPTION EXERCISE | 0.00% | 6.00K | May 12 | View |
| Apr 21, 2020 | Jeffrey Ives | — | 0.00 | $12.97 | -$15.15K | OPTION EXERCISE | 0.00% | 6.00K | Apr 21 | View |
| Apr 21, 2020 | Scott Terrillion | — | 5.61K | $15.56 | -$42.34K | GRANT OR AWARD | 17.13% | 38.38K | Apr 17 - Apr 21 | View |
| Apr 21, 2020 | PhD Frederique Menzaghi | — | 24.61K | $15.58 | -$200.89K | GRANT OR AWARD | 30.80% | 104.49K | Apr 17 - Apr 21 | View |
| Apr 21, 2020 | DEREK CHALMERS | — | 13.65K | $15.56 | -$98.77K | GRANT OR AWARD | 1.41% | 981.42K | Apr 17 - Apr 21 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.